Belgium· BE-AMP-SAM660909-00
Monlutenca 40 GBq/ml
A other therapeutic radiopharmaceuticals product containing lutetium (lu-177) chloride, registered in Belgium by Curium Romania. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Lutetium (lu-177) chloride is registered in 8 of 19 countries.
Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Lutetium (lu-177) chloride · ATC V10X
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Lutetium (Lu-177) Chloride
- Manufacturer
- Curium Romania
- Country
- Belgium (BE)
- ATC code
- V10X
- ATC class
- OTHER THERAPEUTIC RADIOPHARMACEUTICALS
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium (lu-177) chloride in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2cbcbf4a-e2bb-42af-ade7-eca0fc777fa4 GET /v1/drugs/2cbcbf4a-e2bb-42af-ade7-eca0fc777fa4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Radiopharmaceutical precursor, solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Monlutenca 40 GBq/ml",
"name_fr": "Monlutenca 40 GBq/ml",
"name_nl": "Monlutenca 40 GBq/ml",
"amp_code": "SAM660909-00",
"strengths": [
"40.0000",
"40.0000",
"40.0000"
],
"pack_count": 3,
"substances": [
"Lutetium (Lu-177) Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Other Therapeutic Radiopharmaceuticals",
"authorisation_numbers": [
"BE660909"
]
}See everything about lutetium (lu-177) chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.